Generics Though India drug major Cipla (BOM: 500087) recently received approval from the US health regulator for its generic abacavir and lamivudine tablets used for the treatment for HIV infection, some 600 children in India have been battling a shortage of anti-HIV syrup lopinavir, with the National Aids Control Organization (NACO) depleted of its stock of lopinavir and ritonavir syrup, supplied by Cipla, reports The Pharma Letter’s India correspondent. 19 April 2017